A phase II, multi-center, open-label study to evaluate the safety and efficacy of YH003 in combination with toripalimab (anti-PD-1 mAb) in patients with unresectable/metastatic pancreatic ductal adenocarcinoma (PDAC)

Journal

Journal of Clinical Oncology

Series/Report No.

Journal of Clinical Oncology

Journal Volume

42

Journal Issue

16

Start Page

Article number 4146

Date Issued

2024-01-01

Author(s)

Liu D.

Shen, Lin

Ananda, Sumitra

Cao, Dan

Han, Catherine HyeWon

Coward, Jermaine

Chao, Yee

Li, Wei

Dass, Prashanth Hari

Nagrial, Adnan

Huang, Yuan

Ganju, Vinod

Chen, Xiaobing

Cohen, Deirdre J.

Kumar, Rajiv

Bai, Li-Yuan

Yuan, Ying

Chiu, Tai-Jan

URI

Type

journal article